(Approval lapsed) XYLOCAINE-MPF 2% with epinephrine 1:200,000 (400mg lidocaine hydrochloride and 0.1mg epinephrine in 20mL) injection, USP single dose vial (USA)
Section 19A approved medicine
(Approval lapsed) XYLOCAINE-MPF 2% with epinephrine 1:200,000 (400mg lidocaine hydrochloride and 0.1mg epinephrine in 20mL) injection, USP single dose vial (USA)
Section 19A approval holder
Reach Pharmaceuticals Pty Ltd ABN 25 623 897 183
Phone
0422 429 648
Approved until
Status
Expired
Medicines in short supply/unavailable
XYLOCAINE 2% WITH ADRENALINE 1:200,000 20mL injection vial - ARTG 12021
Indication(s)
XYLOCAINE solutions are indicated for the production of local or regional anaesthesia by the following techniques:
- infiltration
- intravenous regional anaesthesia, excluding solutions with adrenaline (epinephrine) acid tartrate
- peripheral nerve block such as intercostal block
- major plexus block such as brachial plexus block
- epidural block
- subarachnoid block.
Images
